Rotation and Restricted Use of Antibiotics in a Medical Intensive Care Unit
- 1 September 2000
- journal article
- Published by American Thoracic Society in American Journal of Respiratory and Critical Care Medicine
- Vol. 162 (3), 837-843
- https://doi.org/10.1164/ajrccm.162.3.9905050
Abstract
To test the hypothesis that a new program of antibiotic strategy control can minimize the incidence of ventilator-associated pneumonia (VAP) caused by potentially antibiotic-resistant microorganisms, we performed a prospective before-after study in 3, 455 patients admitted to a single intensive care unit over a 4-yr period. Regarding the bacterial ecology and the increasing antimicrobial resistance in our medical intensive care unit (MICU), we decided to vary our choice of empiric and therapeutic antibiotic treatment, with a supervised rotation, and a restricted use of ceftazidime and ciprofloxacin, which were widely prescribed before this scheduled change. For all patients, VAP was diagnosed based on the results of quantitative culture of bronchoalveolar lavage specimens (>/= 10(4) cfu/ml). We studied 1,044 and 1,022 patients requiring more than 48 h of mechanical ventilation (MV), respectively, in the before-period (2 yr: 1995-1996) and the after-period (2 yr: 1997-1998). We observed a decrease from 231 consecutive episodes of VAP in the before-period to 161 episodes of VAP in the after-period (p < 0.01), particularly for VAP occurring before 7 d of MV. The total number of potentially antibiotic-resistant gram-negative bacilli responsible for VAP such as Pseudomonas aeruginosa, Burkholderia cepacia, Steno-trophomonas maltophilia, and Acinetobacter baumanii decreased from 140 to 79 isolated bacilli. The susceptibilities of these bacteria to the antibiotics regimen increased significantly, especially for P. aeruginosa and B. cepacia. The percentage of methicillin-sensitive Staphylococcus aureus increased significantly from 40% to 60% of S. aureus responsible for VAP. These results suggest that a new strategy of antibiotics use could be an efficient means to reduce the incidence of VAP caused by antibiotic-resistant bacteria. Nevertheless, further studies are needed to validate these data.Keywords
This publication has 21 references indexed in Scilit:
- Editorial Response: Managing Antibiotic Use‐Impact of Infection ControlClinical Infectious Diseases, 1999
- Society for Healthcare Epidemiology of America and Infectious Diseases Society of America Joint Committee on the Prevention of Antimicrobial Resistance Guidelines for the Prevention of Antimicrobial Resistance in HospitalsInfection Control & Hospital Epidemiology, 1997
- Antimicrobial resistanceCurrent Opinion in Pulmonary Medicine, 1997
- Drug Use Evaluation of Antibiotics in a Pediatric Teaching HospitalInfection Control & Hospital Epidemiology, 1994
- Do Intensive Hospital Antibiotic Control Programs Prevent the Spread of Antibiotic Resistance?Infection Control & Hospital Epidemiology, 1994
- Can Antibiotic Resistance be Controlled?New England Journal of Medicine, 1994
- A New Simplified Acute Physiology Score (SAPS II) Based on a European/North American Multicenter StudyJAMA, 1993
- Characterization of intensive care unit patients using a model based on the presence or absence of organ dysfunctions and/or infection: The ODIN modelIntensive Care Medicine, 1993
- Aminoglycoside resistance and aminoglycoside usage: ten years of experience in one hospitalAntimicrobial Agents and Chemotherapy, 1991
- Antibiotic Misuse in Two Clinical Situations: Positive Blood Culture and Administration of AminoglycosidesClinical Infectious Diseases, 1991